Optimal Duration of Pre-operative Treatment With Letrozole and to Correlate Clinical Efficacy With Appropriate Surrogate Markers
NCT00535418 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 35
Last updated 2017-09-05
Summary
This study will assess optimal duration of pre-operative treatment with letrozole and to correlate clinical efficacy with appropriate surrogate markers.
Conditions
Interventions
- DRUG
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Novartis Pharmaceuticals · Novartis Pharmaceuticals
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-06-30
- Primary Completion
- 2002-07-31
More Related Trials
-
Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer
NCT00332852 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Breast Cancer Prevention by Letrozole in High Risk Women
NCT00579826 ·Status: COMPLETED ·Phase: PHASE2
-
Comparing Letrozole Given Alone to Letrozole Given With Avastin in Post-Menopausal Women Breast Cancer
NCT00530868 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Rheumatologic Tolerability of Letrozole in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer
NCT00329940 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
NCT00553410 ·Status: COMPLETED ·Phase: PHASE3
-
PhII Neo-Adjuvant Letrozole & Lapatinib in Pts w/HER2+ & Hormone Receptor+ Operable Breast CA SPORE
NCT00499681 ·Status: TERMINATED ·Phase: PHASE2
-
A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause
NCT06465368 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Treating Postmenopausal Women With Stage I, II or III Breast Cancer That Can Be Removed by Surgery
NCT00651976 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Extended Adjuvant Treatment With Letrozole in Breast Cancer Who Complete 5 Years of Toremifene
NCT01072318 ·Status: UNKNOWN ·Phase: PHASE4
-
Clinical Outcomes After Letrozole Treatment According to the Estrogen Receptor Expression in Postmenopausal Women
NCT01069211 ·Status: UNKNOWN
-
Study of High-dose Letrozole Therapy in Postmenopausal Patients With Breast Cancer
NCT00237211 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Preventing Breast Cancer in Healthy Postmenopausal Women at High Risk for Breast Cancer
NCT01077453 ·Status: COMPLETED ·Phase: PHASE1
-
Letrozole in Preventing Breast Cancer in Postmenopausal Women Who Are at Increased Risk for Breast Cancer Due to High Breast Density
NCT00238316 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Efficacy and Safety in Premenopausal Women With Hormone Receptor Positive, HER2-negative Advanced Breast Cancer
NCT02278120 ·Status: COMPLETED ·Phase: PHASE3
-
This is a Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study Evaluating the Efficacy and Safety of FCN-437c Versus Placebo in Combination With Letrozole or Anastrozole ± Goserelin in Women With HR+ and HER2- Advanced Breast Cancer.
NCT05439499 ·Status: UNKNOWN ·Phase: PHASE3
-
Letrozole and Goserelin or Leuprolide in Treating Premenopausal Estrogen Receptor-Positive Patients With Stage IV Breast Cancer
NCT00498901 ·Status: TERMINATED ·Phase: PHASE2
-
Comparison Trial of Letrozole to Anastrozole in the Adjuvant Treatment of Postmenopausal Women With Hormone Receptor and Node Positive Breast Cancer
NCT00248170 ·Status: COMPLETED ·Phase: PHASE3
-
Letrozole in Breast Cancer Who Have Received 5 Years of Aromatase Inhibitor Therapy
NCT00754845 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Endocrine Against Locoregional Therapy First in Postmenopausal Women With Early Breast Cancer
NCT00908531 ·Status: TERMINATED ·Phase: PHASE3
-
Everolimus and Letrozole as Preoperative Therapy of Primary Breast Cancer in Post-menopausal Women
NCT00107016 ·Status: COMPLETED ·Phase: PHASE2
-
Study of Safety and Efficacy of Letrozole Monotherapy as Second-line Endocrine Therapy in Postmenopausal Patients With Advanced Breast Cancer Who Received Previous Anti-estrogen Treatment
NCT00237198 ·Status: COMPLETED ·Phase: PHASE2
-
Letrozole in Treating Postmenopausal Women Who Have Received Hormone Therapy for Hormone Receptor-Positive Breast Cancer
NCT00382070 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Letrozole or Tamoxifen in Treating Postmenopausal Women With Breast Cancer
NCT00004205 ·Status: COMPLETED ·Phase: PHASE3
-
Intermittent Letrozole Therapy in Postmenopausal Women With Metastatic Breast Cancer
NCT00549822 ·Status: TERMINATED ·Phase: PHASE2
-
Letrozole In Combination With Lapatinib In Neoadjuvant Treatment Of Early Breast Cancer
NCT00422903 ·Status: COMPLETED ·Phase: PHASE2